Filing Details
- Accession Number:
- 0001127602-12-011602
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-21 13:00:00
- Reporting Period:
- 2012-03-19
- Filing Date:
- 2012-03-21
- Accepted Time:
- 2012-03-21 18:05:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494892 | Frank Haluska | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Svp, Clinical R&D, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-03-19 | 30,000 | $0.00 | 53,865 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-20 | 15,000 | $15.02 | 38,865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2012-03-19 | 30,000 | $0.00 | 30,000 | $0.00 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2012-03-20 | 38,000 | $0.00 | 38,000 | $15.05 |
| Common Stock | Restricted Stock Units | Acquisiton | 2012-03-20 | 18,000 | $0.00 | 18,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-03-22 | No | 4 | M | Direct | |
| 38,000 | 2022-03-20 | No | 4 | A | Direct | |
| 18,000 | 2022-03-20 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- Options vest as to 33-1/3% of the award on each of March 20, 2013, March 20, 2014 and March 20, 2015.
- Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015.
- The restricted stock units vested on March 19, 2012.
- Represents shares withheld to satisfy withhold tax requirements.
- Shares were acquired upon vesting of restricted stock units awarded on March 19, 2009.
- Each restricted stock unit represents a right to receive one share of ARIAD common stock.
Billionaire Hedge Funds
